How can we use GPP to optimize treatment referral among participants enrolled in HIV prevention trial who become HIV infected?
The views expressed herein do not necessarily reflect the official policies of the City and County of San Francisco; nor does
mention of the San Francisco Department of Public Health imply its endorsement. Any questions, comments, or suggestions
pertaining to this site may be directed to firstname.lastname@example.org.